Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-08-15 00:00:00 ET · period of report 2022-08-11 · accession 0001209191-22-045718 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-15 | 2022-08-11 | KPTI | Greene Barry E | Dir | M - OptEx | $1.49 | +7,576 | 13.6K | +126% | +$11.3K |
| D | 2022-08-15 | 2022-08-11 | KPTI | Greene Barry E | Dir | M - OptEx | $0.00 | -7,576 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-11 | M | A | 7,576 | $1.49 | 13,606 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-08-11 | M | D | 7,576 | $0.00 | 0 | D | $1.49 · — to 2023-01-20 | 7,576 Common Stock | (F1) This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 14, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. |